📈 STOCKS | ResMed Gets Bullish Upgrade 🚀
$RMD.US shares jumped nearly 5% Tuesday after RBC Capital Markets upgraded ResMed from Sector Perform → Outperform. 👀
🎯 RBC also raised its price target to $262, up from $244, suggesting around 17% upside from the current $229 level.
The upgrade is based on ResMed’s improving earnings outlook and stronger capital management. RBC expects the medical device and digital health company to potentially deliver high-single-digit earnings growth over the next several years.
Could $RMD be gearing up for another move higher? 📊🔥
#Stocks #RMD #ResMed #Investing #StockMarket
$RMD.US shares jumped nearly 5% Tuesday after RBC Capital Markets upgraded ResMed from Sector Perform → Outperform. 👀
🎯 RBC also raised its price target to $262, up from $244, suggesting around 17% upside from the current $229 level.
The upgrade is based on ResMed’s improving earnings outlook and stronger capital management. RBC expects the medical device and digital health company to potentially deliver high-single-digit earnings growth over the next several years.
Could $RMD be gearing up for another move higher? 📊🔥
#Stocks #RMD #ResMed #Investing #StockMarket
